Flortaucipir (18F) PET Imaging in the BIOCARD Study
Phase of Trial: Phase I
Latest Information Update: 17 Dec 2018
At a glance
- Drugs Flortaucipir-F-18 (Primary)
- Indications Cognition disorders
- Focus Diagnostic use
- Sponsors Avid Radiopharmaceuticals
- 07 Dec 2018 Status changed from recruiting to discontinued study terminated due to lower than expected enrollment
- 01 Mar 2018 Planned End Date changed from 31 Jan 2018 to 31 Jan 2019.
- 01 Mar 2018 Planned primary completion date changed from 31 Jan 2018 to 31 Jan 2019.